Accumulating evidence has demonstrated that elevated expression and polymorphisms of IL1B acted as a crucial risk factor in various cancers, involving cervical cancer, breast cancer, non-small cell lung cancer (46–48). This evidence concerns the gene IL1B and non-small cell lung carcinoma.